Evidence map›Paper›PMID 26870958›Full record

ArticlePLoS neglected tropical diseases2016

Sensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination.

Sumudu Britton, Qin Cheng, Matthew J Grigg, Catherine B Poole, Cielo Pasay, Timothy William, Kimberley Fornace, Nicholas M Anstey, Colin J Sutherland, Chris Drakeley and 1 more

Abstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Rapid diagnostic tests for Plasmodium vivax malaria in endemic countries.The Cochrane database of systematic reviews · 2020
    Pooled it
  4. Pooled it
  5. Microorganisms · 2024
    Review
  6. Recombinase-Aided Loop-Mediated Isothermal Amplification on Human Plasmodium knowlesi.The American journal of tropical medicine and hygiene · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Diagnostic Methods for Non-Falciparum Malaria.Frontiers in cellular and infection microbiology · 2021
    Review
  16. An Ultra-Sensitive Technique: UsingPathogens (Basel, Switzerland) · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sumudu BrittonUniversity of Queensland, Brisbane, Australia and QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Qin ChengAustralian Army Malaria Institute, Brisbane, Australia.
Matthew J GriggMenzies School of Health Research and Charles Darwin University, Darwin, Australia.
Catherine B PooleNew England Biolabs, Ipswich, Massachusetts, United States of America.
Cielo PasayUniversity of Queensland, Brisbane, Australia and QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Timothy WilliamJesselton Medical Centre, Kota Kinabalu, Sabah, Malaysia.
Kimberley FornaceLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Nicholas M AnsteyMenzies School of Health Research and Charles Darwin University, Darwin, Australia.
Colin J SutherlandLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Chris DrakeleyLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
James S McCarthyUniversity of Queensland, Brisbane, Australia and QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Funding

Comparative incidence and clinical spectrum of Plasmodium knowlesi malaria, a longitudinal study in Sabah, MalaysiaR01AI116472 · NIAID · INFECTIOUS DISEASE SOCIETY KOTA KINABALU · PI WILLIAM, TIMOTHY · 2015 to 2019
$682k
Medical Research Council 1100796Medical Research Council G1100796NIAID NIH HHS R01 AI116472
6 · The paper itself

Abstract

introductionPlasmodium vivax malaria has a wide geographic distribution and poses challenges to malaria elimination that are likely to be greater than those of P. falciparum. Diagnostic tools for P. vivax infection in non-reference laboratory settings are limited to microscopy and rapid diagnostic tests but these are unreliable at low parasitemia. The development and validation of a high-throughput and sensitive assay for P. vivax is a priority.

methodsA high-throughput LAMP assay targeting a P. vivax mitochondrial gene and deploying colorimetric detection in a 96-well plate format was developed and evaluated in the laboratory. Diagnostic accuracy was compared against microscopy, antigen detection tests and PCR and validated in samples from malaria patients and community controls in a district hospital setting in Sabah, Malaysia.

resultsThe high throughput LAMP-P. vivax assay (HtLAMP-Pv) performed with an estimated limit of detection of 1.4 parasites/ μL. Assay primers demonstrated cross-reactivity with P. knowlesi but not with other Plasmodium spp. Field testing of HtLAMP-Pv was conducted using 149 samples from symptomatic malaria patients (64 P. vivax, 17 P. falciparum, 56 P. knowlesi, 7 P. malariae, 1 mixed P. knowlesi/P. vivax, with 4 excluded). When compared against multiplex PCR, HtLAMP-Pv demonstrated a sensitivity for P. vivax of 95% (95% CI 87-99%); 61/64), and specificity of 100% (95% CI 86-100%); 25/25) when P. knowlesi samples were excluded. HtLAMP-Pv testing of 112 samples from asymptomatic community controls, 7 of which had submicroscopic P. vivax infections by PCR, showed a sensitivity of 71% (95% CI 29-96%; 5/7) and specificity of 93% (95% CI87-97%; 98/105).

conclusionThis novel HtLAMP-P. vivax assay has the potential to be a useful field applicable molecular diagnostic test for P. vivax infection in elimination settings.

Indexed as

High-Throughput Screening AssaysHumansMalaria, VivaxMalaysiaNucleic Acid Amplification TechniquesPlasmodiumPlasmodium vivax

Identifiers

PMID26870958
PMCPMC4752294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.